Lipid implants for controlled release of biotec drugs
The invention is a lipid based implant, produced by screw extrusion. To achieve good extrudability, very homogeneous drug distribution, excellent mechanical strength, sustained release kinetics with a low burst and mainly stable modification of lipids an inventive lipid mixture has to be applied. The mixture is composed of at least 2 lipids, one of them being a high melting, solid lipid and the other a low melting point lipid. Thereby the lipid mixture can contain low
melting lipids in the form of solid, semisold or liquid lipids at room temperature. After adding the drug with a special procedure the mixture is formed into a solid implant by screw extrusion.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A universal framework for spatial biology
SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…
How complex biological processes arise
A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…